Medtronic disclosed Diabetes unit executive pay packages for 2025 and compensation targets for when they'll lead MiniMed as a ...

With the Own It effort, Medtronic is providing a way for those living with diabetes to celebrate ordinary moments made possible with the right technology so they can own every choice.

Medtronic announced Wednesday that it will spin off its diabetes business into a standalone company. The medical device giant, which is domiciled in Dublin, Ireland but has its main office in Fridley, ...

MiniMed is pitching the breadth of its portfolio as an advantage over more focused rivals such as Dexcom and Insulet.

Medtronic's diabetes business was a sweet spot in the company's fiscal first quarter of 2024. After FDA approved the company's MiniMed 780G system with the Guardian 4 sensor in April, analysts and ...

MiniMed has filed IPO registration with SEC as Medtronic moves forward with the spin off of its diabetes division.

Medtronic has announced plans to separate out its diabetes business into a new standalone company. The separation will serve to create an “independent, scaled leader in diabetes” that boasts an ...

Medtronic will own at least 80.1% of the voting stock for MiniMed once the IPO is complete. It plans to distribute all or ...

This story was originally published on MedTech Dive. To receive daily news and insights, subscribe to our free daily MedTech Dive newsletter. After working for years to turn around its diabetes ...

Health tech company Medtronic is acquiring insulin patch pump company EOFlow for $738 million, the company announced Thursday. The acquisition is meant to bolster Medtronic’s diabetes offerings and ...

In just the last few years, diabetes technology has grown exponentially smarter. Top of mind now for many devicemakers is the creation of a truly closed-loop system for insulin delivery—a system often ...